BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16625816)

  • 1. The role of resistin in obesity-induced insulin resistance.
    Haluzik M; Haluzikova D
    Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of resistin as a regulator of inflammation: Implications for various human pathologies.
    Filková M; Haluzík M; Gay S; Senolt L
    Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current biology of resistin.
    Steppan CM; Lazar MA
    J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistin--resistant to defining its role.
    Smith U
    Obes Res; 2002 Jan; 10(1):61-2. PubMed ID: 11786603
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistin-like molecules and inflammation response].
    Sun Y; Han XZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):616-8. PubMed ID: 18082059
    [No Abstract]   [Full Text] [Related]  

  • 8. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
    Haluzik M
    Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin.
    Cohen G; Hörl WH
    Semin Dial; 2009; 22(4):373-7. PubMed ID: 19708984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes.
    Zhou L; Sell H; Eckardt K; Yang Z; Eckel J
    FEBS Lett; 2007 Sep; 581(22):4303-8. PubMed ID: 17716671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum resistin: physiology, pathophysiology and implications for heart failure.
    Bhalla V; Kalogeropoulos A; Georgiopoulou V; Butler J
    Biomark Med; 2010 Jun; 4(3):445-52. PubMed ID: 20550478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistin and insulin resistance in hepatocytes: resistin disturbs glycogen metabolism at the protein level.
    Yang Y; Xiao M; Mao Y; Li H; Zhao S; Gu Y; Wang R; Yu J; Zhang X; Irwin DM; Niu G; Tan H
    Biomed Pharmacother; 2009 Jun; 63(5):366-74. PubMed ID: 18672341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA
    Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?
    Rea R; Donnelly R
    Diabetes Obes Metab; 2004 May; 6(3):163-70. PubMed ID: 15056123
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
    Tilg H; Moschen AR
    Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of resistin in inflammation and inflammation-related diseases.
    Pang SS; Le YY
    Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide-dependent multimeric assembly of resistin family hormones.
    Patel SD; Rajala MW; Rossetti L; Scherer PE; Shapiro L
    Science; 2004 May; 304(5674):1154-8. PubMed ID: 15155948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.